Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Crawford Nomination Woes Grow With Coburn Hold, Hager Letter

This article was originally published in The Tan Sheet

Executive Summary

FDA Acting Commissioner Lester Crawford's bid for the permanent post has been cast further into doubt by a Republican joining the list of Senators threatening holds on his nomination

You may also be interested in...



FDA Did Not Seek Plan B “Minority Opinion,” Crawford Tells Subcommittee

FDA never asked for or received a memo from former Reproductive Health Drugs Advisory Committee member David Hager, MD, outlining a "minority opinion" on the possible Rx-to-OTC switch of Plan B, Commissioner Lester Crawford stated July 26

FDA Did Not Seek Plan B “Minority Opinion,” Crawford Tells Subcommittee

FDA never asked for or received a memo from former Reproductive Health Drugs Advisory Committee member David Hager, MD, outlining a "minority opinion" on the possible Rx-to-OTC switch of Plan B, Commissioner Lester Crawford stated July 26

FDA Did Not Seek Plan B “Minority Opinion,” Crawford Tells Subcommittee

FDA never asked for or received a memo from former Reproductive Health Drugs Advisory Committee member David Hager, MD, outlining a "minority opinion" on the possible Rx-to-OTC switch of Plan B, Commissioner Lester Crawford stated July 26

Related Content

Topics

UsernamePublicRestriction

Register

PS098191

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel